<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Summary tables</title>
    <link rel="stylesheet" href="/STEVEL-1-Summaries/static/style.css">
    <link rel="icon" href="/STEVEL-1-Summaries/subdex/metabolism.html">
</head>

<body>
    <nav style="margin: 10px 0; text-align: center;">
  <a href="subdex/metabolism.html" class="nav-link">Metabolism Summary</a> |
  <a href="subdex/hemeonc.html" class="nav-link">Heme-Onc Table</a> |
  <a href="subdex/autoantibodies.html" class="nav-link">Autoantibodies</a> |
  <a href="subdex/chromosomes.html" class="nav-link">chromosomes</a> |

<div class="table-container">
  <table class="autoantibody-table">
    <thead>
      <tr>
        <th colspan="6" style="text-align: center; background-color: #d0e5f5;">
          <strong>Heme-Onc Gene Mutations Summary</strong>
        </th>
      </tr>
      <tr>
        <th style="background-color: #f7f9fa;">Disease</th>
        <th style="background-color: #f7f9fa;">Gene / Mutation</th>
        <th style="background-color: #f7f9fa;">Cytogenetics</th>
        <th style="background-color: #f7f9fa;">Mechanism</th>
        <th style="background-color: #f7f9fa;">Category</th>
        <th style="background-color: #f7f9fa;">Lineage</th>
      </tr>
    </thead>
    <tbody>
<tr><td>Chronic Myeloid Leukemia (CML)</td><td>BCR-ABL fusion</td><td>t(9;22), Philadelphia chromosome</td><td>Oncogene activation</td><td>Oncogene</td><td>Myeloid</td></tr>
<tr><td>Acute Promyelocytic Leukemia (APL)</td><td>PML-RARA fusion</td><td>t(15;17)</td><td>Oncogene activation</td><td>Oncogene</td><td>Myeloid</td></tr>
<tr><td>Burkitt Lymphoma</td><td>MYC translocation</td><td>t(8;14)</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Mantle Cell Lymphoma</td><td>Cyclin D1 (CCND1) translocation</td><td>t(11;14)</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Follicular Lymphoma</td><td>BCL2 translocation</td><td>t(14;18)</td><td>Apoptosis inhibition</td><td>Non-Oncogenic</td><td>Lymphoid</td></tr>
<tr><td>Diffuse Large B-Cell Lymphoma</td><td>BCL6 mutations</td><td>various</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Hairy Cell Leukemia</td><td>BRAF V600E mutation</td><td>point mutation</td><td>MAPK pathway activation</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Acute Lymphoblastic Leukemia (ALL)</td><td>TEL-AML1, BCR-ABL</td><td>various</td><td>Fusion oncogenes</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>T-ALL</td><td>NOTCH1 gain-of-function</td><td>point mutation</td><td>T-cell proliferation</td><td>Non-Oncogenic</td><td>Lymphoid</td></tr>
<tr><td>Chronic Lymphocytic Leukemia (CLL)</td><td>Deletion 13q14</td><td>del(13q)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Lymphoid</td></tr>
<tr><td>Multiple Myeloma</td><td>Deletion 17p (TP53)</td><td>del(17p)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Other</td></tr>
<tr><td>Myelodysplastic Syndromes (MDS)</td><td>Deletion 5q</td><td>del(5q)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Myeloid</td></tr>
<tr><td>Polycythemia Vera</td><td>JAK2 V617F</td><td>point mutation</td><td>Tyrosine kinase activation</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Essential Thrombocythemia</td><td>JAK2, CALR, MPL</td><td>point mutations</td><td>Signal transduction</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Primary Myelofibrosis</td><td>JAK2, CALR, MPL</td><td>point mutations</td><td>Signal transduction</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Hemochromatosis</td><td>HFE mutation</td><td>Chromosome 6p21.3</td><td>Iron overload disorder (non-oncogenic)</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Sickle Cell Disease</td><td>HBB gene mutation (Glu6Val)</td><td>Chromosome 11p15.5</td><td>Structural hemoglobinopathy</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Thalassemia (alpha)</td><td>HBA1, HBA2 deletions</td><td>Chromosome 16</td><td>Reduced alpha-globin synthesis</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Thalassemia (beta)</td><td>HBB point mutations</td><td>Chromosome 11</td><td>Reduced beta-globin synthesis</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>G6PD Deficiency</td><td>G6PD mutation</td><td>Xq28</td><td>Enzymopathy – hemolytic anemia</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Hereditary Spherocytosis</td><td>ANK1, SPTB, SPTA1, EPB42</td><td>Various</td><td>Membrane defect (non-oncogenic)</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Fanconi Anemia</td><td>FANC genes</td><td>Various</td><td>DNA repair defect – pancytopenia, ↑ cancer risk</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Paroxysmal Nocturnal Hemoglobinuria</td><td>PIGA mutation</td><td>X chromosome</td><td>Complement regulation defect</td><td>Non-Oncogenic</td><td>Other</td></tr>
    </tbody>
  </table>
</div>
<div class="table-responsive">
  <table border="2" frame="box" rules="all" cellspacing="1" cellpadding="5" style="width:100%; font-family:Arial, sans-serif; font-size:14px;">
    <thead>
      <tr>
        <th colspan="3" style="background-color:#d0e5f5; text-align:center;"><strong>Protein Mutations with Disease Associations</strong></th>
      </tr>
      <tr style="background-color:#f0f8ff;">
        <th>Gene / Protein</th>
        <th>Condition</th>
        <th>Pathophysiology</th>
      </tr>
    </thead>
    <tbody>
      <tr><td>HMGB1</td><td>BPTAS</td><td>Frameshift; disrupts nucleolar phase separation via arginine-rich tails</td></tr>
      <tr><td>SERPINA1</td><td>Alpha-1 Antitrypsin Deficiency</td><td>Loss of protease inhibition → lung & liver damage</td></tr>
      <tr><td>ATM</td><td>Ataxia-Telangiectasia</td><td>Defective DNA repair → neurodegeneration, malignancy</td></tr>
      <tr><td>PEX genes</td><td>Zellweger Spectrum</td><td>Peroxisomal biogenesis defects</td></tr>
      <tr><td>HGD</td><td>Alkaptonuria</td><td>Homogentisate oxidase deficiency → ochronosis</td></tr>
      <tr><td>BTD</td><td>Biotinidase Deficiency</td><td>Impaired biotin recycling → metabolic acidosis</td></tr>
      <tr><td>GALT</td><td>Classic Galactosemia</td><td>Galactose-1-P uridylyltransferase deficiency</td></tr>
      <tr><td>PHKA2</td><td>GSD Type IXa</td><td>Phosphorylase kinase deficiency</td></tr>
      <tr><td>PYGL</td><td>GSD Type VI</td><td>Liver glycogen phosphorylase deficiency</td></tr>
      <tr><td>G6PC</td><td>GSD Type Ia (von Gierke)</td><td>Glucose-6-phosphatase deficiency</td></tr>
      <tr><td>MLH1 / MSH6 / PMS2</td><td>Lynch Syndrome</td><td>Mismatch repair deficiency → colon/endometrial cancer</td></tr>
    </tbody>

    <thead>
      <tr>
        <th colspan="3" style="background-color:#d0e5f5; text-align:center;"><strong>Lysosomal Storage Disorders</strong></th>
      </tr>
      <tr style="background-color:#f0f8ff;">
        <th>Deficient Enzyme</th>
        <th>Disease</th>
        <th>Description</th>
      </tr>
    </thead>
    <tbody>
      <tr><td>IDUA</td><td>MPS I (Hurler)</td><td>α-L-iduronidase deficiency</td></tr>
      <tr><td>IDS</td><td>MPS II (Hunter)</td><td>Iduronate sulfatase deficiency</td></tr>
      <tr><td>Heparan Sulfamidase</td><td>MPS III (Sanfilippo)</td><td>Heparan sulfate degradation defect</td></tr>
      <tr><td>GALNS</td><td>MPS IV (Morquio)</td><td>N-acetylgalactosamine-6-sulfatase deficiency</td></tr>
      <tr><td>ARSB</td><td>MPS VI (Maroteaux-Lamy)</td><td>Arylsulfatase B deficiency</td></tr>
      <tr><td>GUSB</td><td>MPS VII (Sly)</td><td>β-glucuronidase deficiency</td></tr>
      <tr><td>SMPD1</td><td>Niemann-Pick A/B</td><td>Acid sphingomyelinase deficiency</td></tr>
      <tr><td>GALC</td><td>Krabbe Disease</td><td>Galactocerebrosidase deficiency</td></tr>
      <tr><td>ARSA</td><td>Metachromatic Leukodystrophy</td><td>Arylsulfatase A deficiency</td></tr>
      <tr><td>GLB1</td><td>GM1 Gangliosidosis</td><td>β-galactosidase deficiency</td></tr>
      <tr><td>HYAL1</td><td>MPS IX</td><td>Hyaluronidase deficiency</td></tr>
    </tbody>

    <thead>
      <tr>
        <th colspan="3" style="background-color:#d0e5f5; text-align:center;"><strong>Other Enzyme Deficiencies</strong></th>
      </tr>
      <tr style="background-color:#f0f8ff;">
        <th>Enzyme</th>
        <th>Disorder</th>
        <th>Description</th>
      </tr>
    </thead>
    <tbody>
      <tr><td>NAGS</td><td>NAGS Deficiency</td><td>Hyperammonemia due to loss of urea cycle activation</td></tr>
      <tr><td>ASS1</td><td>Citrullinemia Type I</td><td>Argininosuccinate synthetase deficiency</td></tr>
      <tr><td>PCCA / PCCB</td><td>Propionic Acidemia</td><td>Propionyl-CoA carboxylase deficiency</td></tr>
      <tr><td>MUT</td><td>Methylmalonic Acidemia</td><td>Methylmalonyl-CoA mutase deficiency</td></tr>
      <tr><td>IVD</td><td>Isovaleric Acidemia</td><td>Isovaleryl-CoA dehydrogenase deficiency</td></tr>
    </tbody>
  </table>
</div>


</body>


